42 results
8-K
EX-99.1
VERV
Verve Therapeutics Inc
8 May 24
Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results
7:15am
for the company’s Heart-1 clinical trial, including the company’s assessment of the laboratory abnormalities observed in the trial and the company’s
8-K
VERV
Verve Therapeutics Inc
2 Apr 24
Other Events
7:13am
Heart-1 trial, including the Company’s assessment of the laboratory abnormalities observed in the trial and the Company’s interactions with regulatory
424B5
tv455b90i95tzc 8j
29 Nov 23
Prospectus supplement for primary offering
4:47pm
424B5
pmca8a9
28 Nov 23
Prospectus supplement for primary offering
4:25pm
S-3ASR
9o1u xzlz6
23 Sep 22
Automatic shelf registration
4:08pm
S-3ASR
EX-4.4
mivj 2wy8pq4xgr
23 Sep 22
Automatic shelf registration
4:08pm
S-3ASR
EX-4.5
6tdeeb v0dhevwob65ch
23 Sep 22
Automatic shelf registration
4:08pm
424B5
5of9frff s04p4v
21 Jul 22
Prospectus supplement for primary offering
4:43pm